CENTRAL NERVOUS SYSTEM (CNS) MARKET Forecast – 2014 To 2022
In-depth analysis of the market segments that will showcase the greatest growth potential Information about the technological advancements influencing the growth of the global market
Key Benefits Of The Report
Extensive analysis of the key players dominating the competitive landscape of this market
Browse the report :
Central Nervous System (CNS) Market
According to Alzheimer’s Association, as of 2016 5.4 million people are suffering from Alzheimer’s disease in America and these figures will triple up by 2050. It means, one in every nine people above the age of 65 has Alzheimer's disease. This is considered to be one of the major driving factors for the global central nervous system (CNS) market.
Key Premium Industry Insights
The rapidly increasing geriatric population and increasing age of baby boomers are creating a strong rise in the diseases such as Parkinson's, Alzheimer's, and various mental disorders. This is expected to drive the global market during the forecast period. Limited availability of the medicines available for the treatment of the central nervous system-related diseases and disorders is one of the major growth drivers for the global central nervous system (CNS) market. Pharmaceutical companies such as Novartis, Eli Lilly, and GlaxoSmithKline are making heavy investments to develop the most effective drugs for the complete cure of the CNS-related diseases and disorders, which is also considered as one of the growth drivers for this market during the next few years.
Browse the report :
Central Nervous System (CNS) Market
Research Methodology The research methodology for Scalar Market Research’s central nervous system (CNS) market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures highquality data that can be leveraged for actionable research insights. Download Sample :
Central Nervous System (CNS) Market
Market Segmentation Central Nervous System Market, by Neurological Disorders Alzheimer’s Disease Parkinson’s Disease Epilepsy Brain Tumor Stroke Central Nervous System Market, By Mental Disorders Anxiety Disorder Sleep Disorder Mental Retardation Multiple Sclerosis
Novartis A.G. Pfizer, Inc. Johnson and Johnson Eli Lilly and Company Sanofi SA Abbott Laboratories
Key Players
Merck & Co. Bristol Myers Squibb Company Astellas Pharma Inc. GlaxoSmithKline Plc UCB S.A.
Geographic Coverage & Analysis •
Asia-Pacific
•
Europe
•
North America
•
Rest of the World
Find out more about our services at : www.scalarmarketresearch.com Contact : 8770 W Bryn Mawr Ave., Suite 1300 Chicago, IL 60631
Contact Info
Tel. : +1-800-213-5170 (U.S./Canada Toll-free) Email : sales@scalarmarketresearch.com Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research
Related Reports : 1. Biosimilars Market 2. Stem Cell Therapy Market 3. Home Healthcare Market
Thank You